How are donations used?
Since its creation in 1990, the Fondation Charles-Bruneau has invested close to $40 ¬million in the construction and development of various infrastructures used in pediatric oncology, including equipment, at the following hospitals: the CHU Sainte-Justine (Centre de cancérologie Charles-Bruneau), the CHU de Québec (Unité d’oncologie pédiatrique Charles-Bruneau), the CHUS in Sherbrooke (Unité d’oncologie pédiatrique Charles-Bruneau), and the Montreal Children’s Hospital (Centre de traitement de jour en hémato-oncologie Charles-Bruneau). The Fondation has also invested more than $15 million in fundamental research in pediatric oncology and in the development of adjuvant therapies.
The 2015-2016 financial year was a very successful one for the Fondation, which recorded total net revenues of $5,075,919 thanks in large part to its fundraising activities and events.
The Fondation’s administrative costs accounted for only 12.7% of revenues in 2015-2016 — a key indicator of its sound financial health. Moreover, the Fondation was able to continue investing in pediatric oncology research.
Between 2017 and 2022, the Fondation Charles-Bruneau will invest $22 million to prepare the medicine of tomorrow at the Centre de recherche en immuno-hemato-oncologie Charles-Bruneau.
Thank you for your trust.
Download your copy of the 2015-2016 annual report (in French only)